InMed Pharmaceuticals Inc. Common Shares (INM) is a publicly traded Healthcare sector company. As of October 16, 2026, INM trades at $1.34 with a market cap of $7.20M and a P/E ratio of -0.42. INM moved +0.00% today. Year to date, INM is +18.75%; over the trailing twelve months it is -39.55%. Its 52-week range spans $0.58 to $7.98. Rallies surfaces INM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $1.34 |
| Market Cap | $7.20M |
| P/E Ratio | -0.42 |
| EPS |
| $-3.12 |
| Dividend Yield | 0.00% |
|---|
| 52-Week High | $7.98 |
|---|
| 52-Week Low | $0.58 |
|---|
| Volume | 3.79K |
|---|
| Avg Volume | 0 |
|---|
| Revenue (TTM) | $0 |
|---|
| Net Income | $-12.56M |
|---|
| Gross Margin | 0.00% |
|---|
INM analyst coverage data. Average price target: $0.00.